| Active substance |
Atomoxetine |
| Also known as |
Tomoxetine |
| Blood pressure |
Can cause an increase in blood pressure and heart rate |
| Chemical name |
N-methyl-3-phenyl-3-(o-tolyloxy)-propylamine |
| Classification |
Selective Norepinephrine Reuptake Inhibitors |
| Dosage (medical) |
Typically starts at 40 mg per day for adults, adjusted as needed |
| Dosage (sports) |
Not applicable as it is not used for enhancing athletic performance |
| Effects |
Improves attention, reduces impulsivity and hyperactivity in ADHD |
| Formula |
C17H21NO |
| Half-life |
Approximately 5 hours |
| Hepatotoxicity |
Rare, but potential severe liver injury |
| Lab Test |
Not specifically monitored through lab tests, focus is on clinical assessment |
| Main action |
Increases norepinephrine and dopamine levels in the prefrontal cortex |
| Side effects |
Dry mouth, insomnia, decreased appetite, increased blood pressure and heart rate |
| Storage conditions |
Store at room temperature, away from moisture and heat |
| Substance class |
Selective norepinephrine reuptake inhibitor |
| Trade name |
Strattera |
| Use in sports |
None, as it is not anabolic or performance-enhancing |
| WAREHOUSE |
International Warehouse 1 |
| Water Retention |
None |
| Manufacturer |
Healing Pharma |
